tiprankstipranks
Astria Therapeutics appoints Agarwal to board of directors
PremiumThe FlyAstria Therapeutics appoints Agarwal to board of directors
3M ago
Astria Therapeutics price target raised to $22 from $17 at Wedbush
PremiumThe Fly
Astria Therapeutics price target raised to $22 from $17 at Wedbush
4M ago
Spyre Therapeutics price target raised to $54 from $36 at Stifel
PremiumThe Fly
Spyre Therapeutics price target raised to $54 from $36 at Stifel
4M ago
Astria Therapeutics Secures Funds for R&D Through Stock Sale
PremiumCompany AnnouncementsAstria Therapeutics Secures Funds for R&D Through Stock Sale
6M ago
Astria Therapeutics Completes $50M Common Stock Sale
PremiumCompany Announcements
Astria Therapeutics Completes $50M Common Stock Sale
6M ago
Astria Therapeutics 10.34M share Secondary priced at $12.09
PremiumThe Fly
Astria Therapeutics 10.34M share Secondary priced at $12.09
6M ago
Astria Therapeutics reports Q3 EPS (63c), consensus (49c)
PremiumThe FlyAstria Therapeutics reports Q3 EPS (63c), consensus (49c)
8M ago
PremiumEarning Releases
Options Volatility and Implied Earnings Moves Today, November 13, 2023
8M ago
ATXS Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ATXS Upcoming Earnings Report: What to Expect?
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100